Cornercap Investment Counsel Inc Macrogenics Inc Transaction History

Cornercap Investment Counsel Inc

  • $637 Million
  • Q1 2024

A detailed history of Cornercap Investment Counsel Inc transactions in Macrogenics Inc stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 16,217 shares of MGNX stock, worth $68,111. This represents 0.04% of its overall portfolio holdings.

Number of Shares
16,217
Previous 29,110 44.29%
Holding current value
$68,111
Previous $280,000 15.0%
% of portfolio
0.04%
Previous 0.05%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
$9.77 - $21.47 $125,964 - $276,812
-12,893 Reduced 44.29%
16,217 $238,000
Q4 2023

Jan 30, 2024
SELL
$4.48 - $10.11 $27,923 - $63,015
-6,233 Reduced 17.64%
29,110 $280,000
Q3 2023

Nov 13, 2023
SELL
$4.48 - $6.19 $1,747 - $2,414
-390 Reduced 1.09%
35,343 $164,000
Q2 2023

Aug 11, 2023
SELL
$4.62 - $7.54 $72,755 - $118,739
-15,748 Reduced 30.59%
35,733 $191,000
Q1 2023

May 11, 2023
SELL
$4.82 - $7.24 $1,084 - $1,629
-225 Reduced 0.44%
51,481 $369,000
Q4 2022

Feb 13, 2023
SELL
$5.62 - $6.98 $23,778 - $29,532
-4,231 Reduced 7.56%
51,706 $346,000
Q3 2022

Nov 14, 2022
BUY
$3.01 - $5.22 $87,961 - $152,544
29,223 Added 109.39%
55,937 $194,000
Q2 2022

Aug 15, 2022
BUY
$2.25 - $9.99 $60,106 - $266,872
26,714 New
26,714 $79,000

Others Institutions Holding MGNX

# of Institutions
170
Shares Held
62.5M
Call Options Held
819K
Put Options Held
79.4K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $258M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email